EPHRATA MANOR

99 BETHANY ROAD, EPHRATA, PA 17522 (717) 738-4940
Non profit - Corporation 120 Beds Independent Data: November 2025
Trust Grade
86/100
#34 of 653 in PA
Share this report: Email Text Facebook WhatsApp
Last Inspection: September 2024

Within standard 12-15 month inspection cycle. Federal law requires annual inspections.

Overview

Ephrata Manor holds a Trust Grade of B+, indicating it is recommended and above average compared to other nursing homes. It ranks #34 out of 653 facilities in Pennsylvania, placing it in the top half, and is the top option out of 31 facilities in Lancaster County. The facility is improving, with issues decreasing from 7 in 2023 to just 1 in 2024. Staffing is a strength, rated 5 out of 5 stars, with a turnover rate of 28%, much lower than the state average, meaning staff tend to stay and are familiar with the residents' needs. However, the facility has $13,845 in fines, which is average but still raises some concern about compliance issues. Specific incidents of concern include a failure to properly monitor and treat pressure ulcers for one resident, which resulted in harm, as well as not notifying a physician about the development of a pressure ulcer for another resident. Additionally, the facility did not adequately monitor the side effects of anti-psychotic medication for another resident. While strengths like excellent staffing and an improving trend are notable, families should be aware of these weaknesses when considering Ephrata Manor.

Trust Score
B+
86/100
In Pennsylvania
#34/653
Top 5%
Safety Record
Moderate
Needs review
Inspections
Getting Better
7 → 1 violations
Staff Stability
✓ Good
28% annual turnover. Excellent stability, 20 points below Pennsylvania's 48% average. Staff who stay learn residents' needs.
Penalties
⚠ Watch
$13,845 in fines. Higher than 77% of Pennsylvania facilities, suggesting repeated compliance issues.
Skilled Nurses
✓ Good
Each resident gets 45 minutes of Registered Nurse (RN) attention daily — more than average for Pennsylvania. RNs are trained to catch health problems early.
Violations
○ Average
10 deficiencies on record. Average for a facility this size. Mostly minor or procedural issues.
★★★★★
5.0
Overall Rating
★★★★★
5.0
Staff Levels
★★★☆☆
3.0
Care Quality
★★★★☆
4.0
Inspection Score
↔
Stable
2023: 7 issues
2024: 1 issues

The Good

  • 5-Star Staffing Rating · Excellent nurse staffing levels
  • Low Staff Turnover (28%) · Staff stability means consistent care
  • Full Sprinkler Coverage · Fire safety systems throughout facility
  • No fines on record
  • Staff turnover is low (28%)

    20 points below Pennsylvania average of 48%

Facility shows strength in staffing levels, staff retention, fire safety.

The Bad

Federal Fines: $13,845

Below median ($33,413)

Minor penalties assessed

The Ugly 10 deficiencies on record

1 actual harm
Sept 2024 1 deficiency
CONCERN (D)

Potential for Harm - no one hurt, but risky conditions existed

Medication Errors (Tag F0758)

Could have caused harm · This affected 1 resident

Based on a review of the facility's policy, clinical records, and staff interview, it was determined the facility failed to monitor potential side effects of anti-psychotropic medication for one of fi...

Read full inspector narrative →
Based on a review of the facility's policy, clinical records, and staff interview, it was determined the facility failed to monitor potential side effects of anti-psychotropic medication for one of five residents reviewed (Resident 99). Findings include: Review of the facility's policy titled Psychotropic Medications, dated March 2021, revealed the facility would make every effort to comply with state and federal regulations related to the use of psychotropic medications to include regular review for continued need, appropriate dosage, side effects, risk, and benefits. The same policy also indicated potential adverse medication reactions and side effects will be evaluated. Review of Resident 99's physician order dated June 7, 2024, revealed an order for Quetiapine (anti-psychotic medication) 25 mg tablet, three tablets by mouth daily for delusional disorder (mental health condition in which a person cannot tell what is real from what is imagined). Anti-psychotic side effect (monitoring) 1-No side effect; 2-Confusion; 3-Sleep disturbance; 4-Hangover effect; 5-Restlessness with repetitive movements; 6-Uncontrolled muscle spasm, shaking, tremors; 7-Involuntary repetitive movements of the body; 8-Involuntary chewing motion, tongue movements; 9-Stiff neck. Review of Resident 99's physician order dated July 31, 2024, and August 17, 2024, revealed an order for Rexulti (anti-psychotic medication) 2 mg tablet take one tablet by mouth daily. Review of Resident 99's Medication Administration Record failed to reveal potential side effects for Quetiapine and Rexulti were monitored for August 2024, and September 1-19, 2024. Interview with the Director of Nursing was conducted on September 20, 2024, at 10:00 a.m. The Director of Nursing confirmed there were no documented side effects monitoring for both Quetiapine and Rexulti medication. The facility failed to ensure Resident 99 was monitored for the side effects of Quetiapine and Rexulti medications. 28 Pa. Code 211.12(d)(1)(3)(5) Nursing services Previously cited 11/3/23
Nov 2023 7 deficiencies 1 Harm
SERIOUS (G)

Actual Harm - a resident was hurt due to facility failures

Pressure Ulcer Prevention (Tag F0686)

A resident was harmed · This affected 1 resident

Based upon review of facility policy and procedure, clinical record review and interview it was determined the facility failed to provide interventions to prevent pressure ulcers, failed to timely ide...

Read full inspector narrative →
Based upon review of facility policy and procedure, clinical record review and interview it was determined the facility failed to provide interventions to prevent pressure ulcers, failed to timely identify pressure ulcers and failed to provide treatment for pressure ulcers causing harm to one of two residents reviewed (Resident 40). Findings include: Review of facility policy and procedure titled Skin Integrity Program - Pressure Ulcer Prevention/Treatment Program, revised April 27, 2023, revealed Pressure Ulcer Prevention: Every resident shall have a skin risk assessment (Braden Scale) upon admission, return from hospitalization, any significant change in condition and a routine quarterly screening to be completed by a licensed nurse. Further review of this policy revealed A routine skin inspection shall be performed daily as part of their personal hygiene. Further review of this policy revealed For residents determined to be 'at risk' a plan of care shall be implemented to maintain their skin integrity. Further review of this policy revealed Pressure Ulcer Assessment and Treatment: Upon completion of the assessment, the staff shall implement an interdisciplinary plan of care. The identification of risk factors and/or clinical conditions shall be incorporated in the plan of care' A plan to promote wound healing shall be implemented (e.g., films, hydrocolloids, foams, alginates, negative pressure wound therapy), including from excess moisture and incontinence. Review of Resident 40's diagnosis list revealed diagnoses including Alzheimer's disease (irreversible progressive degenerative disease of the brain, resulting in loss of reality contact and functioning ability) and Peripheral Vascular Disease (poor circulation of the extremities). Review of Resident 40's admission Braden Scale for Predicting Pressure Sore Risk dated June 16, 2023, revealed a score of 15. If the score is 18 or less resident is at risk for developing a pressure ulcer. Review of Resident 40's admission Minimum Data Set (MDS - periodic assessment of resident needs) dated June 22, 2023, revealed Resident 40 required extensive assistance of two plus staff members for bed mobility (turning and repositioning while in bed). Review of Resident 40's skin evaluation report dated August 14, 2023, revealed no new skin issues. Review of facility's Skin/Wound Tracking Report revealed on August 15, 2023, the facility identified an open left heel wound, unstageable with slough measuring 1.3 centimeters (cm) x 2.6 cm. Review of Resident 40's clinical record revealed a Wound Healing Solutions report dated August 28, 2023, indicating resident was seen for evaluation and management for newly noted areas of skin breakdown along the left heel. Review of Wound Healing Solutions report dated August 28, 2023, revealed full-thickness wound of the left heel - 1.3 cm x 2.6 cm - wound base 100% stable eschar (dry scab, tan, brown or black in wound bed; dead tissue; black in color in wound bed), no fluctuance noted, edges adherent to the wound base, no drainage noted, periwound without erythema, induration or edema. Further review of the Wound Healing Solutions report dated August 28, 2023, revealed a treatment order to cleanse the affected area with saline solution and apply skin prep daily and PRN (as needed). Review of Resident 40's Treatment Administration Record (TAR) dated August 2023, revealed treatments to the left heel began on August 29, 2023. Further review of Resident 40's TAR failed to reveal evidence that any treatments occurred to Resident 40's left heel from August 15, 2023, when the wound was discovered until August 29, 2023. Review of Resident 40's Skin Conditions care plan revealed that a Skin Conditions care plan was not developed until August 23, 2023. Further review of Resident 40's active care plan failed to reveal evidence that a Skin Condition care plan was initiated upon admission and no interventions were put into place upon admission or prior to the development of the left heel pressure ulcer. Interview with the Director of Nursing on November 3, 2023 at 11:00 a.m. confirmed the facility did not have interventions in place prior to the development of the pressure ulcer, confirmed that no treatments were in place from August 15, 2023 until August 29, 2023 and confirmed that skin evaluations were inaccurate prior to the identification of the wound. The facility failed to prevent the occurrence of a pressure ulcer, failed to timely identify a new pressure ulcer, and failed to treat a new pressure ulcer causing harm to Resident 40. 28 Pa. Code 211.12(c)(d)(1)(2)(3)(5) Nursing Services Previously cited 12/16/2022
CONCERN (D)

Potential for Harm - no one hurt, but risky conditions existed

Notification of Changes (Tag F0580)

Could have caused harm · This affected 1 resident

Based upon clinical record review and interview it was determined the facility failed to notify resident's physician regarding the development of a pressure ulcer for one of two residents reviewed (Re...

Read full inspector narrative →
Based upon clinical record review and interview it was determined the facility failed to notify resident's physician regarding the development of a pressure ulcer for one of two residents reviewed (Resident 40). Findings include: Review of Resident 40's diagnosis list revealed diagnoses including Alzheimer's disease (irreversible progressive degenerative disease of the brain, resulting in loss of reality contact and functioning ability) and Peripheral Vascular Disease (poor circulation of the extremities). Review of facility's Skin/Wound Tracking Report revealed on August 15, 2023, the facility identified an open left heel wound, unstageable with slough measuring 1.3 centimeters (cm) x 2.6 cm. Review of Resident 40's clinical record revealed a Wound Healing Solutions report dated August 28, 2023, indicating resident was seen for evaluation and management for newly noted areas of skin breakdown along the left heel. Review of Wound Healing Solutions report dated August 28, 2023, revealed full-thickness wound of the left heel - 1.3 cm x 2.6 cm - wound base 100% stable eschar (dry scab, tan, brown or black in wound bed; dead tissue; black in color in wound bed), no fluctuance noted, edges adherent to the wound base, no drainage noted, periwound without erythema, induration or edema. Review of Resident 40's clinical record failed to reveal evidence Resident 40's physician was notified of the development of Resident 40's left heel pressure ulcer. Interview with the Director of Nursing on November 3, 2023, at 11:00 a.m. confirmed Resident 40's physician was not notified of Resident 40's change in condition. The facility failed to notify resident's physician of a change in condition. 28 Pa. Code 211.12(c)(d)(1)(2)(3)(5) Nursing Services Previously cited 12/16/2022
CONCERN (D)

Potential for Harm - no one hurt, but risky conditions existed

Deficiency F0638 (Tag F0638)

Could have caused harm · This affected 1 resident

Based on clinical record review and interviews with staff, it was determined that the facility failed to complete a Quarterly MDS assessment at least every three months as required for one of eight re...

Read full inspector narrative →
Based on clinical record review and interviews with staff, it was determined that the facility failed to complete a Quarterly MDS assessment at least every three months as required for one of eight residents reviewed (Resident 100). Findings include: Review of Resident 100's MDS (Minimum Data Set - a mandatory periodic assessment) assessments revealed that the resident had an admission MDS assessment completed on May 29, 2023. Continued review revealed that no further MDS assessments had been completed for Resident 100 since May 29, 2023. Interview on November 3. 2023, at 10:20 a.m. with Employee E3, Registered Nurse Assessment Coordinator, confirmed that Resident 100 had not had an MDS assessment since her admission in May 2023. Employee E3 could not provide an explanation as to why no additional assessments were performed for Resident 100. 28 Pa. Code 211.5(f) Clinical records 28 Pa. Code 211.5(h) Clinical records
CONCERN (D)

Potential for Harm - no one hurt, but risky conditions existed

Comprehensive Care Plan (Tag F0656)

Could have caused harm · This affected 1 resident

Based upon clinical record review and interview it was determined the facility failed to develop a comprehensive care plan for prevention and treatment of pressure ulcers for one of 22 residents revie...

Read full inspector narrative →
Based upon clinical record review and interview it was determined the facility failed to develop a comprehensive care plan for prevention and treatment of pressure ulcers for one of 22 residents reviewed (Resident 40). Findings include: Review of Resident 40's diagnosis list revealed diagnoses including Alzheimer's disease (irreversible progressive degenerative disease of the brain, resulting in loss of reality contact and functioning ability) and Peripheral Vascular Disease (poor circulation of the extremities). Review of Resident 40's admission Braden Scale for Predicting Pressure Sore Risk dated June 16, 2023, revealed a score of 15. If the score is 18 or less resident is at risk for developing a pressure ulcer. Review of Resident 40's admission Minimum Data Set (MDS - periodic assessment of resident needs) dated June 22, 2023, revealed Resident 40 required extensive assistance of two plus staff members for bed mobility (turning and repositioning while in bed). Review of facility's Skin/Wound Tracking Report revealed on August 15, 2023, the facility identified an open left heel wound, unstageable with slough measuring 1.3 centimeters (cm) x 2.6 cm. Review of Resident 40's active care plan failed to reveal evidence that a skin care plan was implemented prior to August 15, 2023, the date upon which Resident 40's pressure ulcer was identified. Interview with the Director of Nursing on November 3, 2023, at 11:00 a.m. confirmed that no care plan was in place prior to the development of Resident 40's pressure ulcer. The facility failed to provide a care plan with interventions for the prevention and/or treatment of Resident 40's pressure ulcer. 28 Pa. Code 211.11(a)(b)(c)(d) Resident care plan 28 Pa. Code 211.12(c)(d)(1)(2)(3)(5) Nursing Services Previously cited 12/16/2022
CONCERN (D)

Potential for Harm - no one hurt, but risky conditions existed

Deficiency F0730 (Tag F0730)

Could have caused harm · This affected 1 resident

Based upon review of staffing records and performance reviews it was determined the facility failed to ensure performance reviews were completed for three of five staffing records reviewed. Findings i...

Read full inspector narrative →
Based upon review of staffing records and performance reviews it was determined the facility failed to ensure performance reviews were completed for three of five staffing records reviewed. Findings include: Review of staffing records and performance reviews revealed three staff members did not have annual performance reviews performed within the appropriate timeframe. Interview with the Nursing Home Administrator (NHA) and Director of Nursing (DON) on November 3, 2023, at 11:27 a.m. confirmed staff performance reviews were not completed timely. Per the DON a performance plan has been made to catch up on past due staff performance reviews. 28 Pa. Code 201.20(a)(c) Staff Development FACILITY
CONCERN (D)

Potential for Harm - no one hurt, but risky conditions existed

Medication Errors (Tag F0758)

Could have caused harm · This affected 1 resident

Based upon clinical record review and staff interview, it was determined the facility failed to ensure that a clinical rationale was provided by residents' physician for not performing a Gradual Dose ...

Read full inspector narrative →
Based upon clinical record review and staff interview, it was determined the facility failed to ensure that a clinical rationale was provided by residents' physician for not performing a Gradual Dose Reduction of an antipsychotic medication and failed to provide a clinical rationale for the continued use beyond 14 days of an as needed anti-anxiety medication for two of five residents reviewed (Resident 38 and Resident 79). Findings include: Review of Resident 38's physician's orders included an order dated December 27, 2022, for Lorazepam (anti-anxiety medication) 0.5 milligrams one tablet by mouth as needed every six hours for anxiety. Review of Resident 38's clinical record revealed a Note to Attending Physician/Prescriber from the consultant pharmacist dated August 11, 2023, with a recommendation to evaluate the use of prn (as needed) Lorazepam. The note indicated that prn psychotropic orders cannot exceed 14 days with the exception that the prescriber documents their rationale in the residents medical record and indicate the duration for the prn order. Review of the physician/prescriber response dated August 21, 2023, indicated to cont.[continue] as ordered. Further review of the clinical record failed to reveal evidence that a clinical rationale or duration was provided as recommended by the pharmacist for the PRN use of Lorazepam. Review of Resident 79's clinical record revealed notes to Attending Physician/Prescriber from the facility pharmacist. Further review of Resident 79's clinical record revealed the facility pharmacist was recommending a Gradual Dose Reduction (GDR) of Resident 79's Seroquel (antipsychotic medication). Review of the physician response to facility pharmacist revealed a note continue as ordered. Further review of the physician response to facility pharmacist failed to reveal a clinical rationale for not performing a GDR as requested by the pharmacist. Further review of Resident 79's clinical record revealed notes to Attending Physician/Prescriber from the facility pharmacist. Further review of Resident 79's clinical record revealed the facility pharmacist indicated that PRN psychotropic orders cannot exceed 14 days. The pharmacist was requesting a clinical rationale for the continued use of PRN Lorazepam beyond the 14 days. Review of the physician response to the PRN Lorazepam request was continue with PRN Ativan. Further review of the clinical record failed to reveal evidence that a clinical rationale was provided as requested by the pharmacist for the PRN use of Lorazepam. Interview with Director of Nursing on November 30, 2023, at 11:15 a.m. confirmed that the physician failed to provide clinical rationales as requested by the facility pharmacist for the continued use of Seroquel and Lorazepam. 28 Pa. Code 211.12(d)(1)(3)(5) Nursing services Previously cited 12/16/2022
CONCERN (D)

Potential for Harm - no one hurt, but risky conditions existed

Deficiency F0947 (Tag F0947)

Could have caused harm · This affected 1 resident

Based upon review of staffing records and inservice documentation, it was determined the facility failed to ensure nurse aides received required 12-hour annual re-training for two of five records revi...

Read full inspector narrative →
Based upon review of staffing records and inservice documentation, it was determined the facility failed to ensure nurse aides received required 12-hour annual re-training for two of five records reviewed. Findings Include: Review of five staffing records and inservice documentation revealed three nurse aides received the required 12-hour annual retraining. Further review of the staffing records and inservice documentation revealed two of the five records reviewed failed to reveal evidence of retraining. Interview with the Nursing Home Administrator and DON on November 3, 2023, at 11:27 a.m. confirmed that the nurse aides did not receive the required in-service retraining within the appropriate timeframe. 28 Pa. Code 201.20(a)(c) Staff Development
Dec 2022 2 deficiencies
CONCERN (D)

Potential for Harm - no one hurt, but risky conditions existed

Drug Regimen Review (Tag F0756)

Could have caused harm · This affected 1 resident

Based upon clinical record review and staff interview, it was determined that the facility failed to ensure that irregularities from the monthly drug regimen review were acted upon by a physician for ...

Read full inspector narrative →
Based upon clinical record review and staff interview, it was determined that the facility failed to ensure that irregularities from the monthly drug regimen review were acted upon by a physician for one of five residents reviewed (Resident 45). Findings include: Review of Resident 45's clinical record revealed that a MRR (Medication Record Review) was completed on June 10, 2022, with a recommendation to evaluate the current dose of Buspar (medication to treat anxiety) and consider a dose reduction. Further review of the clinical record revealed no evidence that the recommendation was acted upon by the physician until a MRR completed on August 17, 2022, revealed a recommendation to address Buspar again. An interview with the Director of Nursing on December 16, 2022, at 9:35 a.m. confirmed that the recommendation was not addressed by the physician until the MRR of August 17, 2022. 28 Pa. Code 211.5(f) Clinical records 28 Pa. Code 211.12(c) Nursing services 28 Pa. Code 211.12(d)(3) Nursing services 28 Pa. Code 211.12(d)(1)(5) Nursing services
CONCERN (D)

Potential for Harm - no one hurt, but risky conditions existed

Medication Errors (Tag F0758)

Could have caused harm · This affected 1 resident

Based on review of facility policy, clinical record review, and staff interview, it was determined that the facility failed to ensure that residents did not receive psychotropoic medications unless ne...

Read full inspector narrative →
Based on review of facility policy, clinical record review, and staff interview, it was determined that the facility failed to ensure that residents did not receive psychotropoic medications unless necessary and that non-pharmacological interventions were attempted before the use of a PRN (as needed) psychotropic medication for two of five residents reviewed (Residents 88 and 90). Findings include: Review of facility policy Psychotropic Medications, reviewed March 2021, revealed that residents do not receive psychotropic medications pursuant to a PRN order unless that medication is necessary to treat a diagnosed specific condition that is documented in the medical record. Non-pharmacological interventions (such as behavioral interventions) are considered and used/care planned when indicated, instead of, or in addition to, medication to assist in the allevation of target behaviors. Review of Resident 88's admission MDS (Minimum Data Set - periodic assessment of resident needs) of March 28, 2022, included diagnoses of CVA (cerebrovascular accident - stroke) and Parkinson's disease (progressive disorder that affects the nervous system and the parts of the body controlled by the nerves). Review of Resident 88's physican's order dated April 20, 2022, reveale an order for Hydroxyzine HCl (medication used to treat anxiety) 25 milligrams one tablet every six hours as needed for anxiety. Review of Resident 88's September 2022 Medication Administration Record (MAR) revealed that PRN Hydroxyzine HCl was administered 18 times. Further review of the clinical record failed to reveal behaviors documented prior to the administration on 15 of 18 occasions. Review of the October 2022 MAR revealed that Hydroxyzine HCL was administered eight times. Further review of the clinical record failed to reveal behaviors documented prior to the administration on six of eight occasions. Review of Resident 88's physician's order dated August 9, 2022, revealed an order for Trazodone (antidepressant medication used to treat sleep disorders) 50 milligrams 0.5 tablet at bedtime as needed for insomnia. Review of Resident 88's September 2022 MAR revealed that PRN Trazodone was administered 17 times. Review of the clinical record revealed no documented evidence that alternate interventions were attempted prior to administration on 14 of 17 occasions. Review of Resident 88's October 2022 MAR revealed that PRNTrazodone was administered 10 times. Review of the clinical record failed to reveal documented evidence that alternate interventions were attempted prior to administration on 8 of 10 occasions. Interview with the Director of Nursing on December 16, 2022, at 1:30 p.m. confirmed that the reasons for the use of the PRN Hydroxyzine were not documented and non-pharmacological interventions were not documented for the use of PRN Trazodone for Resident 88. Review of Resident 90's diagnosis list revealed Alzheimer's Disease (An irreversible, progressive degenerative disease of the brain, resulting in loss of reality contact and functioning ability), and Dementia (A term used to describe a group of symptoms affecting memory, thinking and social abilities severely enough to interfere with daily life) Review of Resident 90's physician's order dated July 23, 2022, revealed an order for Ativan (A medication to treat anxiety) 0.5 mg, give half a tab (.25mg) every four hours as needed for anxiety, restlessness, and agitation. Review of the August 2022, MAR revealed that Resident 90 was administered the PRN Ativan nine times for increased anxiety. Clinical records revealed no documented evidence that an alternative behavior intervention was attempted before the medication administration. Interview with the Director of Nursing was conducted on December 16, 2022, at 12:30 p.m., and confirmed nondrug intervention was not provided before administering PRN Ativan to Resident 90. 28 Pa. Code 201.18(b)(1) Management 28 Pa. Code 211.5(f) Clinical records 28 Pa. Code 211.12(d)(1)(5) Nursing services
Understanding Severity Codes (click to expand)
Life-Threatening (Immediate Jeopardy)
J - Isolated K - Pattern L - Widespread
Actual Harm
G - Isolated H - Pattern I - Widespread
Potential for Harm
D - Isolated E - Pattern F - Widespread
No Harm (Minor)
A - Isolated B - Pattern C - Widespread

Questions to Ask on Your Visit

  • "Can I speak with families of current residents?"
  • "What's your RN coverage like on weekends and overnight?"

Our Honest Assessment

Strengths
  • • Grade B+ (86/100). Above average facility, better than most options in Pennsylvania.
  • • 28% annual turnover. Excellent stability, 20 points below Pennsylvania's 48% average. Staff who stay learn residents' needs.
Concerns
  • • 10 deficiencies on record, including 1 serious (caused harm) violation. Ask about corrective actions taken.
  • • $13,845 in fines. Above average for Pennsylvania. Some compliance problems on record.
Bottom line: Generally positive indicators. Standard due diligence and a personal visit recommended.

About This Facility

What is Ephrata Manor's CMS Rating?

CMS assigns EPHRATA MANOR an overall rating of 5 out of 5 stars, which is considered much above average nationally. Within Pennsylvania, this rating places the facility higher than 99% of the state's 100 nursing homes. This rating reflects solid performance across the metrics CMS uses to evaluate nursing home quality.

How is Ephrata Manor Staffed?

CMS rates EPHRATA MANOR's staffing level at 5 out of 5 stars, which is much above average compared to other nursing homes. Staff turnover is 28%, compared to the Pennsylvania average of 46%. This relatively stable workforce can support continuity of care.

What Have Inspectors Found at Ephrata Manor?

State health inspectors documented 10 deficiencies at EPHRATA MANOR during 2022 to 2024. These included: 1 that caused actual resident harm and 9 with potential for harm. Deficiencies causing actual harm indicate documented cases where residents experienced negative health consequences.

Who Owns and Operates Ephrata Manor?

EPHRATA MANOR is owned by a non-profit organization. Non-profit facilities reinvest revenue into operations rather than distributing to shareholders. The facility operates independently rather than as part of a larger chain. With 120 certified beds and approximately 113 residents (about 94% occupancy), it is a mid-sized facility located in EPHRATA, Pennsylvania.

How Does Ephrata Manor Compare to Other Pennsylvania Nursing Homes?

Compared to the 100 nursing homes in Pennsylvania, EPHRATA MANOR's overall rating (5 stars) is above the state average of 3.0, staff turnover (28%) is significantly lower than the state average of 46%, and health inspection rating (4 stars) is above the national benchmark.

What Should Families Ask When Visiting Ephrata Manor?

Based on this facility's data, families visiting should ask: "Can I visit during a mealtime to observe dining assistance and food quality?" "How do you handle medical emergencies, and what is your hospital transfer rate?" "Can I speak with family members of current residents about their experience?"

Is Ephrata Manor Safe?

Based on CMS inspection data, EPHRATA MANOR has a clean safety record: no substantiated abuse findings (meaning no confirmed cases of resident harm), no Immediate Jeopardy citations (the most serious violation level indicating risk of serious injury or death), and is not on the Special Focus Facility watch list (a federal program monitoring the lowest-performing 1% of nursing homes). The facility has a 5-star overall rating and ranks #1 of 100 nursing homes in Pennsylvania. While no facility is perfect, families should still ask about staff-to-resident ratios and recent inspection results during their visit.

Do Nurses at Ephrata Manor Stick Around?

Staff at EPHRATA MANOR tend to stick around. With a turnover rate of 28%, the facility is 18 percentage points below the Pennsylvania average of 46%. Low turnover is a positive sign. It means caregivers have time to learn each resident's needs, medications, and personal preferences. Consistent staff also notice subtle changes in a resident's condition more quickly. Registered Nurse turnover is also low at 15%, meaning experienced RNs are available to handle complex medical needs.

Was Ephrata Manor Ever Fined?

EPHRATA MANOR has been fined $13,845 across 1 penalty action. This is below the Pennsylvania average of $33,217. While any fine indicates a compliance issue, fines under $50,000 are relatively common and typically reflect isolated problems that were subsequently corrected. Families should ask what specific issues led to these fines and confirm they've been resolved.

Is Ephrata Manor on Any Federal Watch List?

EPHRATA MANOR is not on any federal watch list. The most significant is the Special Focus Facility (SFF) program, which identifies the bottom 1% of nursing homes nationally based on persistent, serious quality problems. Not being on this list means the facility has avoided the pattern of deficiencies that triggers enhanced federal oversight. This is a positive indicator, though families should still review the facility's inspection history directly.

EPHRATA MANOR

99 BETHANY ROAD, EPHRATA, PA 17522 | (717) 738-4940

B+
Trust Grade (86/100)
5.0
CMS Rating
10
Deficiencies

Strengths

  • 5-star staffing
  • Low turnover (28%)

Concerns

  • Review findings

Ask about: Rn Coverage

nursinghomedata.org | Data: CMS November 2025